Characteristics | circFNDC3B expression | |||
---|---|---|---|---|
No. (%) | Low (%) | High (%) | P-value | |
Gender | ||||
Male | 49 (59.8) | 37 (75.5) | 12 (24.5) | 0.560 |
Female | 33 (40.2) | 23 (69.7) | 10 (30.3) | |
Age | ||||
< 60 | 29 (35.4) | 21 (72.4) | 8 (27.6) | 0.909 |
≥ 60 | 53 (64.6) | 39 (73.6) | 14 (26.4) | |
Tumor size | ||||
< 3 cm | 47 (57.3) | 37 (78.7) | 10 (21.3) | 0.189 |
≥ 3 cm | 35 (42.7) | 23 (65.7) | 12 (34.3) | |
Pathology stage | ||||
pTa-pT1 | 28 (34.1) | 13 (46.4) | 15 (53.6) | < 0.0001*** |
pT2-T4 | 54 (65.9) | 47 (87.0) | 7 (13.0) | |
Grade | ||||
Low | 27 (32.9) | 15 (55.6) | 12 (44.4) | 0.012* |
High | 55 (67.1) | 45 (81.8) | 10 (18.2) | |
Lymphatic metastasis | ||||
Yes | 46 (56.1) | 38 (82.6) | 8 (17.4) | 0.029* |
No | 36 (43.9) | 22 (61.1) | 14 (38.9) | |
Vascular invasion | ||||
Yes | 11 (13.4) | 8 (72.7) | 3 (27.3) | 0.975 |
No | 71 (86.6) | 52 (73.2) | 19 (26.8) | |
Recurrence | ||||
Yes | 20 | 14 (70.0) | 6 (30.0) | 0.713 |
No | 62 | 46 (74.2) | 16 (25.8) | |
Total | 82 | 60 | 22 |